Results: Providers did not know whether the drug they prescribed was on the formulary for over 64% of the prescriptions. Physicians were more likely to know whether HMO patients' medications were ...

Hi, it’s Amber in Hong Kong. For many of us, drug labels can be impossible to decipher. A small change may help. But before I ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations ...

Drug testing may be required as a prerequisite for some jobs. State laws may dictate when private employers can require drug tests and how they can use the results. Job candidates for “safety ...

President Joe Biden is granting clemency for nearly 2,500 non-violent drug offenders in his final days in office, placing a focus on sentencing disparities for crack cocaine-related crimes.

Avicanna and Vectura Fertin Pharma are collaborating to establish a joint Scientific and Medical Affairs Committee focused on improving the understanding of medical cannabis access and applications in ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark.

Drug drones being flown into prisons by organised crime gangs could be blocked by “electronic forcefields” that jam their signals. Home Office experts are evaluating the technology which a ...

Ozempic, Wegovy and Other Drugs Are Among 15 Selected for Medicare's Price Negotiations WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to ...

So, Who Benefits From New Cancer Drugs? By Dennis Thompson HealthDay Reporter THURSDAY, Jan. 16, 2025 (HealthDay News) -- Cutting-edge targeted therapies are pushing back the line between life and ...

The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations.